301results about How to "Reduce obesity" patented technology

The invention provides compositions comprising an effective amount of an agent that inhibits a BET protein (e.g., Brd2, Brd3, Brd4), and methods of using such compositions for treating or preventing metabolic syndrome, obesity, type II diabetes, insulin resistance, and related disorders characterized by undesirable alterations in metabolism or fat accumulation.

Dairy or non-diary based fortified carbonated beverage solutions that supply essential nutrients in the human diet. The solution contains per 354 ml, calcium, magnesium and potassium ions in the form of salts and optionally vitamins A, D, C, lutein, zeaxanthin and folic acid in specified amounts to provide dietary supplementation. Sweeteners, stabilizers, flavors and carbonation can also be added to enhance flavor, taste, mouth-feel, ingredient solubilization and product appearance. A method of making the beverages is also described. A method of using carbonation to reduce bacterial counts and reduce degradation of essential nutrients in milk-based beverages with or without pasteurization is also disclosed.

The present invention relates to the phytocannabinoid tetrahydrocannabivarin (THCV) for use in the protection of pancreatic islet cells. Preferably the pancreatic islet cells to be protected are beta cells. More preferably the protection of the pancreatic islet cells maintains insulin production at levels which are able to substantially control or improve control of blood glucose levels in a patient.

The invention discloses weight-losing fruit and vegetable powder which has the characteristics that natural plants with weight-losing effects are taken as raw materials; effective ingredients in the raw materials are retained to the maximum extent by low-temperature extraction and biological enzymolysis technologies; weight-losing factors with relatively good weight-losing effects, such as dietary fibers, plant extracts, tea leaf extract, spice extract, Chinese herbal medicine extracts, probiotic powder, probiotic factors and bamboo charcoal powder, are scientifically compounded on the basis of existing nutritional fruit and vegetable powder; meanwhile, nutritional ingredients with weight-losing effects, such as protein powder, malt extract and malt flour are also compounded, and nutrients such as compound amino acids, vitamins and minerals are added; mainly proceeding from the aspects of satisfying the satiety feel, regulating gastrointestinal florae, protecting the health by traditional Chinese medicines, sucking and removing fat and the like, the digestion and absorption self-regulation capability of a human body is improved, the uptake and secondary synthetic routes of human fat are reduced, the normal nutrient uptake and metabolic level of the human body cannot be influenced, and a good cycle of health protection and weight reduction is realized.

Oil compositions containing Hoodia plant extract dissolved in medium chain tri-acyl-glycerides. Edible emulsions comprising the inventive oil compositions are also disclosed.

A medical implant is disclosed, said implant having a flexible hollow body (1) which can be implanted inside the stomach (8) of a patient and which has a first tube-like end section (2) and a second tube-like end section (3), wherein the first tube-like end section (2) is dimensioned such that it can be fitted into the esophagus (7) of the patient, and the second tube-like end section (3) is dimensioned such that it can be connected to the small intestine loop (9) of the patent in a sealing manner.

The present invention includes compositions and methods of making and using a dietary supplement manufactured from one or more natural polysaccharides previously incubated with a probiotic bacteria in a bioreactor system, wherein the bacteria process the polysaccharides and the resulting processed polysaccharide are provided in the nutritional supplement.

The invention discloses fruit-vegetable nutrition powder and a preparation method thereof. The fruit-vegetable nutrition powder and the preparation method thereof have the advantages that natural plants having weight losing effects are taken as raw materials, low-temperature extraction and biological enzymolysis techniques are adopted, active ingredients in the natural plants are maintained to the greatest extent, weight-losing factors good in weight losing effect, such as dietary fibers, plant extracts, tea extracts, spice extracts, Chinese herb extracts, probiotics powder, probiotics factors and bamboo charcoal powder, are compounded on the basis of existing fruit and vegetable nutrition powder scientifically, nutrient substances with weight losing effects, such as albumen powder, malt extracts and wheat malt powder, are also compounded, nutrients such as compound amino acids, vitamins and mineral substances are added, and automatic regulation, digestion and absorption level and capability of human bodies are maintained and improved in terms of satiety, stomach and intestine flora regulation, traditional Chinese medicine health care, fat absorption and removal and the like, so that intake and secondary synthetic approaches of fat of the human bodies are reduced, normal nutrient ingestion and metabolic levels of the human bodies are not affected, and a virtuous circle of health-care weight loss is achieved.

The use of probiotic bacteria capable of promoting the development of an early bifidogenic intestinal microbiota in the manufacture of a medicament or therapeutic nutritional composition for reducing the risk of development of overweight or obesity of an infant later in life.

Compounds comprising an angiopoietin-like protein 6 (Angptl6) peptide for use in the treatment of metabolic syndrome, in particular, obesity and insulin resistance are described.

The present invention relates to a method for preventing and / or treating visceral adiposity by administering a certain nutritional composition to an infant with the age between 0 and 36 months, and preventing the occurrence of diseases later in life.

A method for the treatment of obesity, diabetes, high cholesterol and related diseases including hyperglycemia, lipid disorders, hyperglyceridemia, dyslipidemia and atherosclerosis in mammals using anthocyanins, anthocyanidins, ursolic acid and / or betulinic acid is described. Compositions adapted for these treatments are also described.

Disclosed is a antihypelipidemic and antihyperglycemic health food for preventing diseases including cardiovascular disease, diabetes, adjusting internal secretion, resisting osteoporosis and cancer, and beauty treatment. The raw materials include soybean powder 15-30 parts, pumpkin powder 15-30 parts, soybean isoflavones 0.5-1.5 parts, soybean saponin 2-5 parts, astragalus root 10-20 parts, wolfberry fruit 10-15 parts, kudzuvine root 10-15 parts, Chinese yam 10-15 parts, lotus plumule 6-10 parts, Siberian solomonseal rhizome 6-10 parts, cassia seed 6-10 parts, lily 5-8 parts, mulberry leaf 5-8 parts and ginseng 3-5 parts.

The invention provides a fat thickness measuring device which comprises an ultrasonic probe, a control unit, a display unit and a power supply unit, wherein the ultrasonic probe is used for emitting ultrasonic wave to an object to be measured, receiving ultrasonic echoes of the ultrasonic wave emitted by the ultrasonic probe at the same time, and outputting received ultrasonic echo signals; the control unit is used for controlling the ultrasonic probe to emit the ultrasonic wave, receiving the ultrasonic echo signals outputted by the ultrasonic probe, processing and calculating the ultrasonic echo signals, obtaining the fat thickness of the object to be measured through calculation, and then outputting fat thickness data; the display unit is used for receiving and displaying the fat thickness data outputted by the control unit; and the power supply unit is used for providing electric energy for the ultrasonic probe, the control unit and the display unit. The fat thickness measuring device is small in size, convenient to carry, easy to operate, visualized in numerical reading, and especially suitable for fat thickness monitoring utilization by an individual of families or fitness centers.

The invention discloses seasoning fruit and vegetable powder. Natural plants with the antiobesity effect are used as raw materials, and the low-temperature extraction and biological enzymolysis technologies are adopted to preserve the effective ingredients to the largest extent; on the basis of the conventional fruit and vegetable powder, antiobesity factors with better antiobesity effect, such as dietary fibers, plant extracts, tea extracts, spice extracts, Chinese herb extracts, probiotic powder, beneficial factors and bamboo charcoal powder, are scientifically compounded, nutrient substances with the antiobesity effect, such as albumen powder, malt extracts and wheat malt powder, are further compounded, and compound amino acid, vitamins, minerals and other nutrients are added. Mainly aimed at various purposes of achieving satiety, adjusting bacterial colonies in the stomach and the intestines, preserving health through traditional Chinese medicines, and suctioning and discharging fat, the seasoning fruit and vegetable powder can maintain and improve the self-adjusted digestion and absorption levels and capacities of human bodies, reduce fat ingestion and secondary synthesis pathways of human bodies, have no effects on normal nutrient digestion and metabolism levels of human bodies, and achieve a virtuous circle for health preservation and weight loss.

A Chinese medicine in the form of capsule for treating hyperlipemia and fatty liver and lossing weight is prepared from 16 Chinese-medicinal materials including tetrandra root, alismatis rhizome, white mustard seed, peach kernel, etc. Its advantage is high curative effect.

The present invention discloses compounds of Formula I: (I) having 11beta-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as the use of the Fomula I and compositions as medicaments to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, Syndrome X, and other conditions associated with hyperglycemia.

The invention relates to bifidobacterium longum subsp. infantis CCFM687 as well as fermented food and application thereof. The bifidobacterium longum subsp. infantis CCFM687 provided by the inventioncan improve the depressive behavior of a depression mouse and raise the level of 5-hydroxytryptamine, 5-hydroxytryptophane and brain-derived neurotrophic factor in the brain of the depression mouse; moreover, the content of butyric acid in the intestines of the depression mouse is increased; the abundance of intestinal desulfovibrio is lowered while the abundance of bifidobacterium and S24-7 family is raised, the intestinal flora alpha-diversity is improved, the intestinal flora disturbance of the depression mouse is relieved, and the occurrence of autism, inflammatory bowel disease, obesity,diabetes mellitus type I and the like is reduced; the level of mRNA simulating tryptophan hydroxylase in enterochromaffin cell is raised, the secretion of 5-hydroxytryptophane of the enterochromaffincell is increased, and a precursor substance is provided for the synthesis of 5-hydroxytryptamine in brain. Therefore, the bifidobacterium longum subsp. infantis CCFM687 has a broad application value.

The invention belongs to the technical field of deep processing methods of subsidiary agricultural products, and particularly relates to a method for extracting extracting ponkan dietary fibers through extrusion modification and enzymolysis coupling. The method comprises the steps of by taking ponkan hide trimmings as raw material, carrying out hot ironing, drying, grinding, mixing and extrusion modification, adding water for dispersion, adjusting the pH, adding compound enzyme for enzymolysis, carrying out enzyme deactivation and centrifugation to obtain filtrate and precipitate, carrying out concentration, alcohol precipitation, alcohol washing, centrifugation and drying on the filtrate to obtain water-soluble dietary fibers, and carrying water washing, centrifugation and drying on the precipitate to obtain insoluble dietary fibers. According to the method for extracting extracting ponkan dietary fibers through extrusion modification and enzymolysis coupling, the content of the dietary fibers in the ponkan hide trimmings is improved, the functionality of the ponkan hide trimmings is strengthened, meanwhile, a new path is provided for the comprehensive utilization of the ponkan by-products, the deep processing of the subsidiary agricultural products is realized and the resource waste is decreased.

The invention is directed to methods for treating and / or controlling obesity in a patient. The methods involve combination therapies using a microsomal triglyceride transfer protein (MTP) inhibitor (for example, AEGR-733 and implitapide) and a cholesterol absorption inhibitor (CAI) (for example, ezetimibe).

The character is to delimit scope in deep water area at selected lake shore band at first, then to select plants, the third is to set plants row pitch, the fourth is to set anti-wave layer and fix wood pile, the fifth is to set wave-proof layer which is made by pilling wood pile at internal side of anti-wave player and fitting iron plate on the wood pile and float wave-proof layer which is made by polyfoam, the sixth is to set planting position of emergent aquatic plant and submerged plant, the seventh is maintenance.

A novel, new, and highly effective agent for promoting fat degradation that contains astaxanthin and / or an ester thereof as active ingredient is provided. The agent for promoting fat degradation of the present invention has an effect of reducing fat by lipolysis of fat in either a subject who is in a condition in which fat has already accumulated or a subject who is in a condition in which fat has not yet been accumulated. Accordingly, the agent for promoting fat degradation of the present invention can restore hypertrophied adipocytes to a normal size.

The present invention relates to synergistic compositions comprising mixtures of fermentable fibers. The present invention specifically relates to composition comprising inulin and arabinoxylan for use in reducing, preventing and / or treating inflammation, wherein said arabinoxylan is partially hydrolyzed arabinoxylan and wherein the ratio of said inulin to said arabinoxylan and / or partially hydrolyzed arabinoxylan is between 65% / 35% by weight and 90% / 10% by weight.

The present invention provides compounds of formula I that are useful as potent and selective inhibitors of 11-beta hydroxysteroid dehydrogenase 1. The present invention further provides a pharmaceutical composition which comprises a compound of Formula I, or a pharmaceutical salt thereof, and a pharmaceutically acceptable carrier, diluent, or excipient. In addition, the present invention provides compositions comprising compounds of formula I for the treatment of metabolic syndrome, diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, other symptoms associated with hyperglycemia, and related disorders. Formula (I) wherein, Ru0 is (II), or (III) G1 is methylene or ethylene; L is a divalent linking group selected from —(C1-C4) alkylene-, —S—, —CH(OH)—, or —O—; A is methylene, —S—, —O—, or —NH—; and the other substituents are as defined in the claims.

The present invention provides compounds of formula I that are useful as potent and selective inhibitors of 11-beta hydroxysteroid dehydrogenase 1. The present invention further provides a pharmaceutical composition which comprises a compound of Formula I, or a pharmaceutical salt thereof, and a pharmaceutically acceptable carrier, diluent, or excipient. In addition, the present invention compositions containing these compounds for the treatment of metabolic syndrome, diabetes, hyperglycemia obesity, hypertension, hyperlipidemia, other symptoms associated with hyperglycemia, and related disorders. Formula I wherein G1 is methylene or ethylene; L is —(C1-C4)alkylene-, —S—, —CH(OH)—, or —O—; R0 is Formula II or Formula III and the other substituents are as defined in the claims.

A medical implant is disclosed, said implant having a flexible hollow body (1) which can be implanted inside the stomach (8) of a patient and which has a first tube-like end section (2) and a second tube-like end section (3), wherein the first tube-like end section (2) is dimensioned such that it can be fitted into the esophagus (7) of the patient, and the second tube-like end section (3) is dimensioned such that it can be connected to the small intestine loop (9) of the patent in a sealing manner.

The present invention relates to a rear balance walking shoe having a sole in which double earth axes are formed on the sole at a rear side with respect to the middle of the sole, and the heel and the toe of the sole are elevated from respective double earth axes and perform see-saw motions at the double earth axes serving as application points. By wearing these shoes, the center of gravity of a wearer's body is inclined backward, resulting in reduction of obesity by activating muscles of the trunk. Still further, since a wearer feels comfortable even if the wearer wears the shoes for a long time and can reduce impact transferred to the wearer's feet, an exercise effect is enhanced.

The invention relates to a green papaya chewing tablet made from natural plant fruit papaya, which mainly contains the materials of green papaya powder, sweetener and adhesives; the preparation method comprises following steps: making green papaya powder first; mixing the green papaya powder with other materials; making the mixture into particle materials; drying the particle materials with low temperature; squashing the particle materials into tablets; finally packing the tablets to obtain the product. The green papaya chewing tablet has the advantages of strengthening spleen and stomach, helping digestion, relieving constipation, detoxicating and deswelling, improving lactation, preserving continence, preventing tooth decay, anti-tumor, reducing weight, enlarging breast, and being suitable for general population, more particularly for the female friends.

Provided herein are pharmaceutical and cosmetic formulations and methods for regional adiposity reduction and treatment of body contour defects such as abdominal bulging; comprising an injectable formulation, said formulation comprising: an active ingredient that consists essentially of an adipose tissue-reducing amount of one or more lipophilic long-acting selective beta-2 adrenergic receptor agonists, or salts, solvates, or polymorphs thereof; and one or more subcutaneously acceptable inactive ingredients.